Bio-Techne Corporation (TECH)
Bio-Techne Corporation (TECH) Stock Price, Analysis & Data
| Bid | 66.3 |
| Market Cap | 11.28B |
| Revenue (ttm) | 1.22B |
| Net Income (ttm) | 181.86M |
| Beta | 1.28 |
| EPS (ttm) | 1.16 |
| PE Ratio (ttm) | 62.41 |
| Forward PE | 31.25 |
| P/B (ttm) | 5.43 |
| P/S (ttm) | 9.28 |
| Earnings Date | Nov 9, 2026 |
| Ask | 77.83 |
| Volume | 2,000,181 |
| Avg. Volume (20D) | 4,860,332 |
| Open | 72.18 |
| Previous Close | 72.17 |
| Day's Range | 72.08 - 72.42 |
| 52-Week Range | 43.20 - 72.43 |
| Analyst | Hold |
| Price Target | 73 (0.83%) |
| Dividends | $0.32 (0.44%) |
| Ex-Dividend Date | Aug 17, 2026 |
About TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cel...
Financial Performance
In 2025, Bio-Techne's revenue was 1.22B, an increase of 5.23% compared to the previous year's 1.16B. Earnings were 73.4M, a decrease of -56.34%.
Financial StatementsAnalyst Forecast
According to 11 analyst ratings, the average rating for TECH stock is "Hold". The 12-month stock price forecast is 73, which is upside of 0.83% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
